NPI | Name | Type | Address |
---|---|---|---|
Margaret Puchaev |
Individual |
560 1st Ave New York, NY |
|
Mei-ting Wong |
Individual |
New York University Langone Medical Center 550 1st Ave New York, NY |
|
Julia Choi |
Individual |
160 E 53rd St New York, NY |
|
PHARMD Laura Tang |
Individual |
1275 York Ave New York, NY |
|
DR. PHARMD Josiah David Land |
Individual |
1275 York Ave New York, NY |
|
PHARMACIST Michael David Masterson |
Individual |
3 Crossing Blvd Halfmoon, NY |
|
DR. PHARM.D, Nina Dipierro |
Individual |
160 E 53rd St New York, NY |
|
Meagan Griffin |
Individual |
1275 York Ave New York, NY |
|
PHARMD Kristen Marie Poppiti |
Individual |
1250 1st Ave Schwartz 710 New York, NY |
|
PHARM.D Dazhi Liu |
Individual |
1275 York Ave New York, NY |
|
DR. PHARMD Carmen Lau |
Individual |
1275 York Avenue Schwartz-710 New York, NY |
|
DR. PHARMD Bernadette Catherine Loughlin |
Individual |
1275 York Ave Room C-1087 New York, NY |
|
PHARM.D. V Park |
Individual |
405 Lexington Ave New York, NY |
|
DR. PHARMD Frank A Surita |
Individual |
650 Commack Rd Commack, NY |
|
DR. PHARMD Brianne Dixon |
Individual |
1275 York Ave New York, NY |
|
DR. PHARMD Jeremy Pappacena |
Individual |
1275 York Ave New York, NY |
|
PHARMD Charlene Claire Kabel |
Individual |
1275 York Ave New York, NY |
|
Jennifer Robin Gruber |
Individual |
640 Ellicott St Ste 301 Buffalo, NY |
|
MR. PHARM. D. Alexandros Argyris |
Individual |
1274 Nostrand Ave Brooklyn, NY |
|
PHARMD Arwa Mohamed |
Individual |
500 Westchester Ave West Harrison, NY |
Every health care provider, whether it’s a hospital, pharmacy, or individual specialist, must obtain their own NPI number. This identification number is unique and is assigned upon application. In tod...
Taxonomy Code | 1835X0200X |
Specialization | Oncology |
Display Name | Oncology Pharmacist |
Taxonomy Group | Pharmacy Service Providers |
Taxonomy Classification | Pharmacist |
Definition | A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases. |
Effective Date | September 30, 2009 |